SVA.TO SERNOVA BIOTHERAPEUTICS INC
$0.14▼ -3.57%
Healthcare
Other
Volume 547.5K
Avg Volume (10D) 267.6K
Key Metrics & Fundamentals
Market Cap
$50.98M
P/E Ratio
–
Div Yield
–%
52W Range
0.10 - 0.20
% vs 50 MA
15.19%
% vs 200 MA
-7.57%
RSI-14
67.5
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.53
Free Cash Flow
-$2.21M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.29M
COGS
–
Operating Exp
$2.30M
Operating Income
-$2.30M
EBIT
-$2.30M
Pretax Income
-$3.23M
Net Income
-$3.23M
EPS (Diluted)
-0.01
Price & Volume History
Loading chart…
Recent News
Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc.
TMX Newsfile · Sep 11, 2026 9:40 PM
Sernova Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investor Conference
GlobeNewswire · Sep 10, 2026 11:00 AM
Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics
GlobeNewswire · Sep 8, 2026 11:00 AM
Cell Encapsulation Global Market Report 2026-2035 | Features Strategic Profiles of Beta-Cell, Betalin Therapeutics, Beta-O2 Technologies, Diatranz Otsuka, Neurotech, Semma Therapeutics, Sernova, ViaCyte
GlobeNewswire · Aug 26, 2026 1:33 PM
Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy
GlobeNewswire · Jun 17, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See SVA.TO's money flow as a full page
Social Sentiment
No Reddit posts found for SVA.TO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.